FT | June 10, 2021, 8:08 a.m.
AstraZeneca’s vaccine has saved many thousands of lives. But rare side-effects, and, relative to competitors, lower efficacy against new variants have given it an uncertain outlook. Coupled with a multibillion-euro lawsuit over delivery shortfalls, the UK pharma group’s future role in the ongoing battle against Covid-19 is under scrutinyRead Full Article
Tech in Asia | June 15, 2021, 6:30 a.m.
Broadband TV News | June 15, 2021, 6:29 a.m.
Tech in Asia | June 15, 2021, 6:28 a.m.
Fleet News | June 15, 2021, 6:24 a.m.